Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial - Griffin - 2024 - The Journal of Pathology: Clinical Research - Wiley Online Library …thsocjournals.onlinelibrary.wiley.com/doi/10.1002/20…

We are excited to announce that meeting registration and abstract submission for the 2024 IBCN Annual Meeting in Bern, Switzerland is now OPEN! Please visit ibcnweb.com for all the details. #IBCN2024 Peter Black Tilman Todenhöfer Roland Seiler-Blarer Lars Dyrskjøt Kent Mouw

Just a little life update. September 2024 just got a lot more interesting! #newjob #scientist #professor Vancouver Prostate Centre University of British Columbia

Drum roll please.... super excited to welcome Ewan Gibb to Vancouver Prostate Centre and UBCUrology as research scientist and assistant prof. With a decade of genomics/transcriptomics research under his belt, Ewan will have immediate impact on our bladder and prostate programs. 🤝👏👍👊

We are hiring a regular, fulltime HR and Office Administrator to join the Vancouver Prostate Centre; see our website for further information including how to apply prostatecentre.com/about-us/curre…

Congrats to my new boss!

#PURE01 trial did it again! Distinct Gene Expression Patterns Identify Pts who Relapse After Neoadjuvant Pembro and RC. Neuroendocrine pattern worst outcome (to be excluded from IO trials) and zero relapses in Claudin-low subtypes Chiara Mercinelli Brigida Maiorano Antonio Cigliola

Excellent opportunity for a medical oncologist McGill University Centre universitaire de santé McGill to join a collaborative and enriched academic environment in the wonderful city of #montreal. Please apply or RT

#IBCN2024 GUSTO Trial using molecular subtyping @NHS trial highlighted by Jon Griffin UroToday.com IBCN

Ewan Gibb presenting #IBCN24 IBCN AI subtype prediction neoadjuvant response in MIBC. Impressive talk/session and brilliant work. More to come from Peter Black Vancouver Prostate Centre UBCUrology! 🔥👍💫 IBCG UroToday.com BladderCancerCanada Bladder Cancer Advocacy Network

That’s a wrap on a record breaking #IBCN2024! Hope everyone can join us next year in Munich!

😭😭😭

A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy - Jong - BJU International - Wiley Online Library bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj… Joep J. de Jong

The non-coding RNA based classifier identifies urothelial carcinomas harboring less aggressive tumor biology associated with favorable outcomes after radical cystectomy Joep J. de Jong UT Southwestern Urology Sia Daneshmand, M.D. Roger Li Elai Davicioni Decipher by Veracyte doi.org/10.1111/bju.16…

Congratulations to Dr. Joshua Scurll on being awarded the UBC Science Co-op Supervisor Recognition Award for 2024! Click to read more: prostatecentre.com/news/dr-scurll…… #Awards #research #UBC

“Our findings suggest that molecular subtyping information provided by the Decipher Bladder test can help clinicians better identify which patients may benefit from more-intensive treatment with neoadjuvant chemotherapy," says Yair Lotan, MD. UT Southwestern Urology urologytimes.com/view/genomic-s…

Dr. Nada Lallous has received an Idea Development Award from the U.S. DoD Prostate Cancer Research Program. This $1.48M grant supports her collaborative study on androgen receptor condensates in treatment-resistant prostate cancer. prostatecentre.com/news/dr-lallou…

First paper out from my lab! 🎉 Thrilled to share our work on molecular profiling of Ta low-grade bladder cancer, published in European Urology Oncology: 🔗sciencedirect.com/science/articl… Many thanks to Joep J. de Jong, Peter Black, and Lars Dyrskjøt! #bladdercancer #genomics #NMIBC #uroonc

On behalf of Vancouver Prostate Centre, I’m proud to host the inaugural Life Sciences Data Association Vancouver (LDAV) event on July 17. Talks, ideas, and connections at the data + life sciences interface. RSVP: tinyurl.com/LDAVevent #LDAV #Vancouver #lifesciences #datascience

⚡️ A new study identifies a scar-like transcriptomic profile in residual muscle-invasive bladder cancer post-neoadjuvant therapy, linked to a favorable prognosis. This molecular signature could help stratify patients after cystectomy. #BladderCancer #Immunotherapy